Prevention and attenuation of Covid-19 with the BNT162b2 and mRNA-1273 vaccines
…, T Zunie, MS Thiese, L Ivacic, MG Wesley… - … England Journal of …, 2021 - Mass Medical Soc
Background Information is limited regarding the effectiveness of the two-dose messenger
RNA (mRNA) vaccines BNT162b2 (Pfizer–BioNTech) and mRNA-1273 (Moderna) in …
RNA (mRNA) vaccines BNT162b2 (Pfizer–BioNTech) and mRNA-1273 (Moderna) in …
Incidence of influenza during pregnancy and association with pregnancy and perinatal outcomes in three middle-income countries: a multisite prospective longitudinal …
…, MG Wesley, MG Thompson, G Soto… - The Lancet Infectious …, 2021 - thelancet.com
Background Influenza vaccination during pregnancy prevents influenza among women and
their infants but remains underused among pregnant women. We aimed to quantify the risk …
their infants but remains underused among pregnant women. We aimed to quantify the risk …
Comparison of the immunogenicity of cell culture-based and recombinant quadrivalent influenza vaccines to conventional egg-based quadrivalent influenza vaccines …
…, M Mishina, SS Kim, MG Wesley… - Clinical Infectious …, 2021 - academic.oup.com
Background RIV4 and cell-culture based inactivated influenza vaccine (ccIIV4) have not been
compared to egg-based IIV4 in healthcare personnel, a population with frequent influenza …
compared to egg-based IIV4 in healthcare personnel, a population with frequent influenza …
[HTML][HTML] Research on the epidemiology of SARS-CoV-2 in essential response personnel (RECOVER): protocol for a multisite longitudinal cohort study
LJ Edwards, AL Fowlkes, MG Wesley… - JMIR research …, 2021 - researchprotocols.org
Background Workers critical to emergency response and continuity of essential services
during the COVID-19 pandemic are at a disproportionally high risk of SARS-CoV-2 infection. …
during the COVID-19 pandemic are at a disproportionally high risk of SARS-CoV-2 infection. …
[HTML][HTML] Risk factors for reinfection with SARS-CoV-2 Omicron variant among previously infected frontline workers
…, K Respet, Z Baccam, MG Wesley… - Emerging infectious …, 2023 - ncbi.nlm.nih.gov
In a cohort of essential workers in the United States previously infected with SARS-CoV-2,
risk factors for reinfection included being unvaccinated, infrequent mask use, time since first …
risk factors for reinfection included being unvaccinated, infrequent mask use, time since first …
Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines
…, AL Naleway, K Murthy, HC Groom, MG Wesley… - Nature …, 2024 - nature.com
Repeat vaccination with egg-based influenza vaccines could preferentially boost antibodies
targeting the egg-adapted epitopes and reduce immunogenicity to circulating viruses. In this …
targeting the egg-adapted epitopes and reduce immunogenicity to circulating viruses. In this …
Effect of repeat vaccination on immunogenicity of quadrivalent cell-culture and recombinant influenza vaccines among healthcare personnel aged 18–64 years: a …
…, S Ball, Z Jeddy, D Hunt, MG Wesley… - Clinical Infectious …, 2023 - academic.oup.com
Background Antibody responses to non–egg-based standard-dose cell-culture influenza
vaccine (containing 15 µg hemagglutinin [HA]/component) and recombinant vaccine (…
vaccine (containing 15 µg hemagglutinin [HA]/component) and recombinant vaccine (…
Sustained release of neurotrophin‐3 via calcium phosphate‐coated sutures promotes axonal regeneration after spinal cord injury
…, JS Lee, CJ Madura, MG Wesley… - Journal of …, 2016 - Wiley Online Library
Because of the dynamics of spinal cord injury (SCI), the optimal treatment will almost certainly
be a combination approach to control the environment and promote axonal growth. This …
be a combination approach to control the environment and promote axonal growth. This …
Neutralizing antibody response to pseudotype severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) differs between mRNA-1273 and BNT162b2 …
…, S Rose, H Groom, J Meece, MG Wesley… - Clinical infectious …, 2022 - academic.oup.com
Background Data on the development of neutralizing antibodies (nAbs) against SARS-CoV-2
after SARS-CoV-2 infection and after vaccination with mRNA COVID-19 vaccines are …
after SARS-CoV-2 infection and after vaccination with mRNA COVID-19 vaccines are …
Consistency of self‐reported and documented historical influenza vaccination status of US healthcare workers
Background Healthcare personnel (HCP) are a priority group for annual influenza vaccination.
Few studies have assessed the validity of recall of prior influenza vaccination status …
Few studies have assessed the validity of recall of prior influenza vaccination status …
